Site 03: Accelovance — Rockville, Maryland

Site 03: Accelovance is a clinical research site located in Rockville, Maryland, United States 20850.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site 03: Accelovance has participated in 1 clinical trials.

Therapeutic areas: H7N9 Influenza.

Sponsors: Novartis Vaccines.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site 03: Accelovance?

Site 03: Accelovance has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site 03: Accelovance conducted?

Site 03: Accelovance has 1 clinical trials on record. Their work covers H7N9 Influenza.

Is Site 03: Accelovance accredited by Crixeo Health?

Site 03: Accelovance has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site 03: Accelovance?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.